Capital Research Global Investors Neuronetics, Inc. Transaction History

Capital Research Global Investors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$1.28 - $4.5 $1.09 Million - $3.81 Million	-847,721 Closed	0 $0
Q4 2019 Feb 18, 2020	SELL	$4.03 - $9.22 $3.39 Million - $7.77 Million	-842,322 Reduced 49.84%	847,721 $3.81 Million
Q3 2019 Nov 14, 2019	BUY	$8.31 - $13.03 $166,200 - $260,600	20,000 Added 1.2%	1,690,043 $14 Million
Q1 2019 May 15, 2019	BUY	$13.6 - $19.58 $12 Million - $17.3 Million	883,143 Added 112.23%	1,670,043 $25.5 Million
Q4 2018 Feb 14, 2019	BUY	$16.0 - $31.84 $5 Million - $9.94 Million	312,256 Added 65.79%	786,900 $15.2 Million
Q3 2018 Nov 14, 2018	BUY	$24.32 - $37.54 $2.42 Million - $3.74 Million	99,644 Added 26.57%	474,644 $15.2 Million
Q2 2018 Aug 14, 2018	BUY	$26.61 - $27.78 $9.98 Million - $10.4 Million	375,000 New	375,000 $9.98 Million

11.8M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $118M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

Stay updated on Capital Research Global Investors with notifications on news.